Intellia Therapeutics, Inc. is a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology. The company's mission is to develop curative genome editing treatments that can positively transform the lives of patients living with severe and life-threatening diseases. Intellia's pipeline includes programs focused on genetic diseases, liver diseases, and cancer. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.
Highest paying job titles at Intellia Therapeutics, Inc. include Intellectual Property Counsel, Senior Software Development Engineer, and Senior UI Software Engineer